WO2000036127A1 - Procede pour augmenter la teneur en composes soufres et notamment en cysteine, methionine et glutathion chez les plantes et plantes obtenues - Google Patents
Procede pour augmenter la teneur en composes soufres et notamment en cysteine, methionine et glutathion chez les plantes et plantes obtenues Download PDFInfo
- Publication number
- WO2000036127A1 WO2000036127A1 PCT/FR1999/003179 FR9903179W WO0036127A1 WO 2000036127 A1 WO2000036127 A1 WO 2000036127A1 FR 9903179 W FR9903179 W FR 9903179W WO 0036127 A1 WO0036127 A1 WO 0036127A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- sat
- plant
- plants
- cysteine
- transit peptide
- Prior art date
Links
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 title claims abstract description 123
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 title claims abstract description 113
- 235000018417 cysteine Nutrition 0.000 title claims abstract description 113
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 title claims abstract description 86
- 238000000034 method Methods 0.000 title claims abstract description 75
- 229930182817 methionine Natural products 0.000 title claims abstract description 60
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 title claims abstract description 59
- 108010024636 Glutathione Proteins 0.000 title claims abstract description 43
- 229960003180 glutathione Drugs 0.000 title claims abstract description 43
- 230000001965 increasing effect Effects 0.000 title claims abstract description 17
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical class [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 title description 22
- 238000004519 manufacturing process Methods 0.000 claims abstract description 7
- 241000196324 Embryophyta Species 0.000 claims description 250
- 108090000623 proteins and genes Proteins 0.000 claims description 135
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 82
- 210000004027 cell Anatomy 0.000 claims description 77
- 102000004169 proteins and genes Human genes 0.000 claims description 52
- 235000018102 proteins Nutrition 0.000 claims description 51
- 210000003763 chloroplast Anatomy 0.000 claims description 43
- 235000001014 amino acid Nutrition 0.000 claims description 37
- 229910052717 sulfur Inorganic materials 0.000 claims description 34
- 239000011593 sulfur Substances 0.000 claims description 34
- 230000001086 cytosolic effect Effects 0.000 claims description 29
- 150000001413 amino acids Chemical class 0.000 claims description 27
- 230000009466 transformation Effects 0.000 claims description 23
- 244000061176 Nicotiana tabacum Species 0.000 claims description 22
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 22
- 230000001105 regulatory effect Effects 0.000 claims description 21
- 230000001580 bacterial effect Effects 0.000 claims description 20
- 239000013598 vector Substances 0.000 claims description 20
- 210000003470 mitochondria Anatomy 0.000 claims description 17
- 108020001507 fusion proteins Proteins 0.000 claims description 15
- 102000037865 fusion proteins Human genes 0.000 claims description 15
- -1 heliantinin Proteins 0.000 claims description 15
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 14
- 210000000805 cytoplasm Anatomy 0.000 claims description 14
- 230000002438 mitochondrial effect Effects 0.000 claims description 14
- 150000007523 nucleic acids Chemical group 0.000 claims description 14
- 102100034274 Diamine acetyltransferase 1 Human genes 0.000 claims description 13
- 101000641077 Homo sapiens Diamine acetyltransferase 1 Proteins 0.000 claims description 13
- 101000713305 Homo sapiens Sodium-coupled neutral amino acid transporter 1 Proteins 0.000 claims description 13
- 241000588724 Escherichia coli Species 0.000 claims description 11
- 240000008042 Zea mays Species 0.000 claims description 8
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 8
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 8
- 235000005822 corn Nutrition 0.000 claims description 8
- 210000002706 plastid Anatomy 0.000 claims description 8
- 241000219195 Arabidopsis thaliana Species 0.000 claims description 7
- 108091026890 Coding region Proteins 0.000 claims description 7
- 108010076504 Protein Sorting Signals Proteins 0.000 claims description 7
- 230000001413 cellular effect Effects 0.000 claims description 7
- 235000010469 Glycine max Nutrition 0.000 claims description 6
- 238000010367 cloning Methods 0.000 claims description 6
- 244000068988 Glycine max Species 0.000 claims description 5
- 240000007594 Oryza sativa Species 0.000 claims description 5
- 235000007164 Oryza sativa Nutrition 0.000 claims description 5
- 108010064851 Plant Proteins Proteins 0.000 claims description 5
- 230000001419 dependent effect Effects 0.000 claims description 5
- 235000021118 plant-derived protein Nutrition 0.000 claims description 5
- 230000025540 plastid localization Effects 0.000 claims description 5
- 235000009566 rice Nutrition 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 claims description 4
- 235000016068 Berberis vulgaris Nutrition 0.000 claims description 4
- 241000335053 Beta vulgaris Species 0.000 claims description 4
- 240000002791 Brassica napus Species 0.000 claims description 4
- 235000004977 Brassica sinapistrum Nutrition 0.000 claims description 4
- 229920000742 Cotton Polymers 0.000 claims description 4
- 240000000111 Saccharum officinarum Species 0.000 claims description 4
- 235000007201 Saccharum officinarum Nutrition 0.000 claims description 4
- 210000004899 c-terminal region Anatomy 0.000 claims description 4
- 108020004707 nucleic acids Proteins 0.000 claims description 4
- 102000039446 nucleic acids Human genes 0.000 claims description 4
- 230000001131 transforming effect Effects 0.000 claims description 4
- 241000228212 Aspergillus Species 0.000 claims description 3
- 241000235648 Pichia Species 0.000 claims description 3
- 241000235070 Saccharomyces Species 0.000 claims description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 3
- 241000219793 Trifolium Species 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 235000013339 cereals Nutrition 0.000 claims description 3
- 230000004927 fusion Effects 0.000 claims description 3
- 230000010354 integration Effects 0.000 claims description 3
- 150000003463 sulfur Chemical class 0.000 claims description 3
- 241000701447 unidentified baculovirus Species 0.000 claims description 3
- 108010020183 3-phosphoshikimate 1-carboxyvinyltransferase Proteins 0.000 claims description 2
- 108010088751 Albumins Proteins 0.000 claims description 2
- 102000009027 Albumins Human genes 0.000 claims description 2
- 108020004998 Chloroplast DNA Proteins 0.000 claims description 2
- 229920002494 Zein Polymers 0.000 claims description 2
- 239000013599 cloning vector Substances 0.000 claims description 2
- 239000013604 expression vector Substances 0.000 claims description 2
- 108010050792 glutenin Proteins 0.000 claims description 2
- 230000003612 virological effect Effects 0.000 claims description 2
- 239000005019 zein Substances 0.000 claims description 2
- 229940093612 zein Drugs 0.000 claims description 2
- 241000233866 Fungi Species 0.000 claims 2
- 244000299507 Gossypium hirsutum Species 0.000 claims 2
- 241000235649 Kluyveromyces Species 0.000 claims 2
- 101000640813 Homo sapiens Sodium-coupled neutral amino acid transporter 2 Proteins 0.000 claims 1
- 101000716973 Homo sapiens Thialysine N-epsilon-acetyltransferase Proteins 0.000 claims 1
- 101710089395 Oleosin Proteins 0.000 claims 1
- 108010003581 Ribulose-bisphosphate carboxylase Proteins 0.000 claims 1
- 101150077669 SAT4 gene Proteins 0.000 claims 1
- 101100450131 Schizosaccharomyces pombe (strain 972 / ATCC 24843) hal4 gene Proteins 0.000 claims 1
- 101710140501 Sulfate adenylyltransferase subunit 2 1 Proteins 0.000 claims 1
- 102100020926 Thialysine N-epsilon-acetyltransferase Human genes 0.000 claims 1
- 238000002703 mutagenesis Methods 0.000 claims 1
- 231100000350 mutagenesis Toxicity 0.000 claims 1
- 108091022908 Serine O-acetyltransferase Proteins 0.000 abstract description 185
- 230000002018 overexpression Effects 0.000 abstract description 6
- 230000000694 effects Effects 0.000 description 57
- 230000015572 biosynthetic process Effects 0.000 description 54
- 238000003786 synthesis reaction Methods 0.000 description 47
- 102000004190 Enzymes Human genes 0.000 description 46
- 108090000790 Enzymes Proteins 0.000 description 46
- 229940024606 amino acid Drugs 0.000 description 33
- VZXPDPZARILFQX-BYPYZUCNSA-N O-acetyl-L-serine Chemical compound CC(=O)OC[C@H]([NH3+])C([O-])=O VZXPDPZARILFQX-BYPYZUCNSA-N 0.000 description 25
- 238000004458 analytical method Methods 0.000 description 25
- 230000014509 gene expression Effects 0.000 description 25
- 108700019146 Transgenes Proteins 0.000 description 22
- 102000004196 processed proteins & peptides Human genes 0.000 description 21
- 108010029485 Protein Isoforms Proteins 0.000 description 20
- 102000001708 Protein Isoforms Human genes 0.000 description 20
- 240000004713 Pisum sativum Species 0.000 description 18
- 235000010582 Pisum sativum Nutrition 0.000 description 18
- 230000005764 inhibitory process Effects 0.000 description 16
- 108700027408 O-acetylhomoserine (thiol)-lyase Proteins 0.000 description 15
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 15
- 210000000172 cytosol Anatomy 0.000 description 14
- 101000737578 Arabidopsis thaliana Bifunctional cystathionine gamma-lyase/cysteine synthase Proteins 0.000 description 12
- 230000009261 transgenic effect Effects 0.000 description 12
- 101000889837 Aeropyrum pernix (strain ATCC 700893 / DSM 11879 / JCM 9820 / NBRC 100138 / K1) Protein CysO Proteins 0.000 description 11
- 230000000670 limiting effect Effects 0.000 description 11
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 10
- YDBYJHTYSHBBAU-YFKPBYRVSA-N S-methyl-L-methioninate Chemical compound C[S+](C)CC[C@H](N)C([O-])=O YDBYJHTYSHBBAU-YFKPBYRVSA-N 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 10
- 230000002255 enzymatic effect Effects 0.000 description 10
- 229960005173 methiosulfonium chloride Drugs 0.000 description 10
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 9
- 230000037361 pathway Effects 0.000 description 9
- 239000000872 buffer Substances 0.000 description 8
- 230000000875 corresponding effect Effects 0.000 description 8
- 238000004128 high performance liquid chromatography Methods 0.000 description 8
- ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 description 8
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 7
- 238000011534 incubation Methods 0.000 description 7
- 239000003550 marker Substances 0.000 description 7
- 239000002243 precursor Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 229960001153 serine Drugs 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- 150000003464 sulfur compounds Chemical class 0.000 description 7
- YPWSLBHSMIKTPR-UHFFFAOYSA-N Cystathionine Natural products OC(=O)C(N)CCSSCC(N)C(O)=O YPWSLBHSMIKTPR-UHFFFAOYSA-N 0.000 description 6
- ILRYLPWNYFXEMH-UHFFFAOYSA-N D-cystathionine Natural products OC(=O)C(N)CCSCC(N)C(O)=O ILRYLPWNYFXEMH-UHFFFAOYSA-N 0.000 description 6
- ILRYLPWNYFXEMH-WHFBIAKZSA-N L-cystathionine Chemical compound [O-]C(=O)[C@@H]([NH3+])CCSC[C@H]([NH3+])C([O-])=O ILRYLPWNYFXEMH-WHFBIAKZSA-N 0.000 description 6
- 238000002955 isolation Methods 0.000 description 6
- 239000002773 nucleotide Substances 0.000 description 6
- 125000003729 nucleotide group Chemical group 0.000 description 6
- 235000016709 nutrition Nutrition 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 241000701489 Cauliflower mosaic virus Species 0.000 description 5
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 5
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 5
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 description 5
- 108010022348 Sulfate adenylyltransferase Proteins 0.000 description 5
- 229960001570 ademetionine Drugs 0.000 description 5
- 229940009098 aspartate Drugs 0.000 description 5
- 238000012512 characterization method Methods 0.000 description 5
- 239000007795 chemical reaction product Substances 0.000 description 5
- 238000010276 construction Methods 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 239000005090 green fluorescent protein Substances 0.000 description 5
- 210000003463 organelle Anatomy 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 5
- 230000035882 stress Effects 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 102100040149 Adenylyl-sulfate kinase Human genes 0.000 description 4
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 102100031974 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4 Human genes 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 101000703754 Homo sapiens CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4 Proteins 0.000 description 4
- 239000004201 L-cysteine Substances 0.000 description 4
- 235000013878 L-cysteine Nutrition 0.000 description 4
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 4
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 4
- 239000004472 Lysine Substances 0.000 description 4
- 102000004523 Sulfate Adenylyltransferase Human genes 0.000 description 4
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 4
- 239000004473 Threonine Substances 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 230000009418 agronomic effect Effects 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 230000002950 deficient Effects 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 229930027917 kanamycin Natural products 0.000 description 4
- 229960000318 kanamycin Drugs 0.000 description 4
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 4
- 229930182823 kanamycin A Natural products 0.000 description 4
- 235000021374 legumes Nutrition 0.000 description 4
- 230000004807 localization Effects 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 108010058731 nopaline synthase Proteins 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 229920001184 polypeptide Polymers 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 238000012026 site acceptance test Methods 0.000 description 4
- 108010032655 Adenylyl-sulfate reductase Proteins 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- 108091092195 Intron Proteins 0.000 description 3
- RITKHVBHSGLULN-WHFBIAKZSA-N L-gamma-glutamyl-L-cysteine Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(O)=O RITKHVBHSGLULN-WHFBIAKZSA-N 0.000 description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 3
- 108090000856 Lyases Proteins 0.000 description 3
- 102000004317 Lyases Human genes 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 108010061618 O-succinylhomoserine (thiol)-lyase Proteins 0.000 description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
- 244000300264 Spinacia oleracea Species 0.000 description 3
- 235000009337 Spinacia oleracea Nutrition 0.000 description 3
- 108010091582 Sulfate Transporters Proteins 0.000 description 3
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 3
- 239000012190 activator Substances 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 230000002596 correlated effect Effects 0.000 description 3
- 239000000539 dimer Substances 0.000 description 3
- 238000010494 dissociation reaction Methods 0.000 description 3
- 230000005593 dissociations Effects 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 238000006911 enzymatic reaction Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 108010068906 gamma-glutamylcysteine Proteins 0.000 description 3
- 229930195712 glutamate Natural products 0.000 description 3
- 239000004009 herbicide Substances 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000008488 polyadenylation Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 210000001938 protoplast Anatomy 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 230000008685 targeting Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 150000003573 thiols Chemical class 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 241000088885 Chlorops Species 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- 108010076010 Cystathionine beta-lyase Proteins 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 241000219146 Gossypium Species 0.000 description 2
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 2
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 2
- 108010033040 Histones Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- 108010025815 Kanamycin Kinase Proteins 0.000 description 2
- 241000209510 Liliopsida Species 0.000 description 2
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 102000018509 Sulfate Transporters Human genes 0.000 description 2
- 108010027912 Sulfite Oxidase Proteins 0.000 description 2
- 102000043440 Sulfite oxidase Human genes 0.000 description 2
- 241000723873 Tobacco mosaic virus Species 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 102000005421 acetyltransferase Human genes 0.000 description 2
- 108020002494 acetyltransferase Proteins 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 235000019728 animal nutrition Nutrition 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 239000007833 carbon precursor Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 229930002875 chlorophyll Natural products 0.000 description 2
- 235000019804 chlorophyll Nutrition 0.000 description 2
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 244000038559 crop plants Species 0.000 description 2
- 230000008260 defense mechanism Effects 0.000 description 2
- 238000001212 derivatisation Methods 0.000 description 2
- 239000012636 effector Substances 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 241001233957 eudicotyledons Species 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- 230000002101 lytic effect Effects 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000007069 methylation reaction Methods 0.000 description 2
- 230000025608 mitochondrion localization Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 238000012261 overproduction Methods 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000004850 protein–protein interaction Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000009738 saturating Methods 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- MSTNYGQPCMXVAQ-RYUDHWBXSA-N (6S)-5,6,7,8-tetrahydrofolic acid Chemical compound C([C@H]1CNC=2N=C(NC(=O)C=2N1)N)NC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 MSTNYGQPCMXVAQ-RYUDHWBXSA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- VHJLVAABSRFDPM-UHFFFAOYSA-N 1,4-dithiothreitol Chemical compound SCC(O)C(O)CS VHJLVAABSRFDPM-UHFFFAOYSA-N 0.000 description 1
- PRPINYUDVPFIRX-UHFFFAOYSA-N 1-naphthaleneacetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CC=CC2=C1 PRPINYUDVPFIRX-UHFFFAOYSA-N 0.000 description 1
- 101150090724 3 gene Proteins 0.000 description 1
- 108010071218 3'-phosphoadenylyl-5'-phosphosulfate reductase Proteins 0.000 description 1
- 101150033839 4 gene Proteins 0.000 description 1
- 108010075604 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase Proteins 0.000 description 1
- 102000011848 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase Human genes 0.000 description 1
- 108091006112 ATPases Proteins 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 241000589156 Agrobacterium rhizogenes Species 0.000 description 1
- VWEWCZSUWOEEFM-WDSKDSINSA-N Ala-Gly-Ala-Gly Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(O)=O VWEWCZSUWOEEFM-WDSKDSINSA-N 0.000 description 1
- 101710150200 Albumin-8 Proteins 0.000 description 1
- 108010055400 Aspartate kinase Proteins 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 108010049994 Chloroplast Proteins Proteins 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 241001533384 Circovirus Species 0.000 description 1
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 1
- 102000000541 Defensins Human genes 0.000 description 1
- 108010002069 Defensins Proteins 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 101100422538 Escherichia coli sat-2 gene Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
- 108010060309 Glucuronidase Proteins 0.000 description 1
- 108010070675 Glutathione transferase Proteins 0.000 description 1
- 239000005562 Glyphosate Substances 0.000 description 1
- 108050002220 Green fluorescent protein, GFP Proteins 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 102100029100 Hematopoietic prostaglandin D synthase Human genes 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 108010064711 Homoserine dehydrogenase Proteins 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 241000219745 Lupinus Species 0.000 description 1
- 240000004658 Medicago sativa Species 0.000 description 1
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 1
- JJIHLJJYMXLCOY-BYPYZUCNSA-N N-acetyl-L-serine Chemical compound CC(=O)N[C@@H](CO)C(O)=O JJIHLJJYMXLCOY-BYPYZUCNSA-N 0.000 description 1
- UOHFOHPESIWBCK-DKWTVANSSA-N N[C@@H](CO)C(=O)O.[C] Chemical compound N[C@@H](CO)C(=O)O.[C] UOHFOHPESIWBCK-DKWTVANSSA-N 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- FXDNYOANAXWZHG-UHFFFAOYSA-N O-phospho-L-homoserine Natural products OC(=O)C(N)CCOP(O)(O)=O FXDNYOANAXWZHG-UHFFFAOYSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108090000417 Oxygenases Proteins 0.000 description 1
- 102000004020 Oxygenases Human genes 0.000 description 1
- 108010076986 Phytochelatins Proteins 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- DFPOZTRSOAQFIK-UHFFFAOYSA-N S,S-dimethyl-beta-propiothetin Chemical compound C[S+](C)CCC([O-])=O DFPOZTRSOAQFIK-UHFFFAOYSA-N 0.000 description 1
- 101150021047 SAT3 gene Proteins 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 235000012377 Salvia columbariae var. columbariae Nutrition 0.000 description 1
- 240000005481 Salvia hispanica Species 0.000 description 1
- 235000001498 Salvia hispanica Nutrition 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 102100030113 Sulfate transporter Human genes 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 229920000398 Thiolyte Polymers 0.000 description 1
- 241000723792 Tobacco etch virus Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 229940100228 acetyl coenzyme a Drugs 0.000 description 1
- 230000003281 allosteric effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- GINJFDRNADDBIN-FXQIFTODSA-N bilanafos Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCP(C)(O)=O GINJFDRNADDBIN-FXQIFTODSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000014167 chia Nutrition 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 1
- 239000005516 coenzyme A Substances 0.000 description 1
- 229940093530 coenzyme a Drugs 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 239000012483 derivatization solution Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000020930 dietary requirements Nutrition 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229940014144 folate Drugs 0.000 description 1
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 238000001641 gel filtration chromatography Methods 0.000 description 1
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 description 1
- 229940097068 glyphosate Drugs 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- FBPFZTCFMRRESA-UHFFFAOYSA-N hexane-1,2,3,4,5,6-hexol Chemical compound OCC(O)C(O)C(O)C(O)CO FBPFZTCFMRRESA-UHFFFAOYSA-N 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910052816 inorganic phosphate Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 150000002545 isoxazoles Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- AHEWZZJEDQVLOP-UHFFFAOYSA-N monobromobimane Chemical class BrCC1=C(C)C(=O)N2N1C(C)=C(C)C2=O AHEWZZJEDQVLOP-UHFFFAOYSA-N 0.000 description 1
- 239000006870 ms-medium Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 230000036963 noncompetitive effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 125000001741 organic sulfur group Chemical group 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000012514 protein characterization Methods 0.000 description 1
- 230000026447 protein localization Effects 0.000 description 1
- 230000014493 regulation of gene expression Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000004960 subcellular localization Effects 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000005460 tetrahydrofolate Substances 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 239000002676 xenobiotic agent Substances 0.000 description 1
- 230000002034 xenobiotic effect Effects 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8251—Amino acid content, e.g. synthetic storage proteins, altering amino acid biosynthesis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8251—Amino acid content, e.g. synthetic storage proteins, altering amino acid biosynthesis
- C12N15/8253—Methionine or cysteine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8251—Amino acid content, e.g. synthetic storage proteins, altering amino acid biosynthesis
- C12N15/8254—Tryptophan or lysine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
Definitions
- Methionine is the first essential limiting amino acid in plants, in particular legumes, which are one of the bases of animal nutrition. Cysteine, another sulfur amino acid, is not an essential amino acid, but can be considered as a limiting element for animal nutrition since cysteine is derived, in animals, from methionine. In corn, sulfur amino acids are also limiting amino acids after lysine and tryptophan. In fact, the majority of reserve proteins in the seeds of these plants are poor in these amino acids. The overproduction of methionine and cysteine in the seeds of legumes (soybeans, alfalfa, peas, ...) and corn will therefore have a considerable impact on the nutritional quality of these seeds.
- the increase in the nutritional quality of foods derived from legume seeds has been obtained by supplementation with chemically synthesized free methionine.
- the average methionine + cysteine content of soybeans and peas is around 20 mg per g of protein. This content must be increased to a value of around 25 mg cysteine + methionine / g of protein to cover the dietary requirements of adult humans, and to a value of around 48 mg of cysteine + methionine / g of proteins to cover those of pigs (De Lumen, BO, Food Technology (1997) 51, 67-70).
- plants overexpressing a protein rich in methionine and cysteine in their seed have a lower methionine, free cysteine and also glutathione level than the control plants ([ 2] Tabe, L. & Droux, M., 4 , h Workshop on Sulfur Metabolim, in press).
- peptides rich in sulfur amino acids exhibiting antifungal or antibacterial activity have been identified (WO 97/30082, WO 99/02717, WO 9909184, WO 99/24594, WO 99/53053).
- the expression of these peptides in plants increases the ability of said plants to resist certain fungal or bacterial attacks. Again, the production of such peptides in plants remains limited to the ability of plant cells and plants to produce the sulfur-containing amines necessary for the synthesis of these peptides. Indeed, the expression of these peptides in the plant cell is at the expense of the glutathione stock, considered as a reservoir for cysteine.
- cysteine In plants, the biosynthesis of methionine is carried out from cysteine, this same cysteine being involved in the synthesis of glutathione.
- Glutathione is a form of storage of reduced sulfur and represents 60 to 70% of organic sulfur in the cell. Glutathione plays an important role for plants in resistance against oxidative stress and the elimination of toxic compounds. It thus participates in the elimination of xenobiotic compounds: heavy metals (for example) via the formation of phytochelatins and metallothionines; herbicides, via glutathione S-transferase activity; which are toxic to the plant, and in the plant's defense mechanisms against microorganisms.
- heavy metals for example
- herbicides via glutathione S-transferase activity
- glutathione S-transferase activity which are toxic to the plant, and in the plant's defense mechanisms against microorganisms.
- cysteine two distinct pathways, one for the preparation of methionine, the other for the preparation of glutathione ( Figure 1) and the various enzymes involved are set out below.
- the SAT (El) and OASTL (E2) activities are at a metabolic crossroads between the assimilation of nitrogen and organic carbon (serine) and inorganic sulfur (reduced sulfur resulting from the sequence of assimilation and reduction of sulphate , gray frame). Cysteine is then incorporated into proteins, but also participates in the synthesis of glutathione and methionine. For this last amino acid, the synthesis of its carbon skeleton (O- ph ⁇ sphohomoserine) is derived from aspartate.
- the aspartate is also the precursor in the synthesis of lysine, threonine and isoleucine.
- the diagram indicates the presence of a potential limiting step for the synthesis of methionine, by regulation at the transcriptional level of CGS (cystathionine ⁇ -synthase) ([3] Giovanelli J. in Sulfur Nutrition and Sulfur Assimilation in Higher Plants, (1990) pp. 33-48; [4] Chiba Y. & al. (1999), Science. 286, 1371-1374).
- Methionine is the precursor of SAM (S-adenosylmethionine) involved in most methylation reactions, and of SMM (S-methylmethionine) considered as a form of transport and storage of methionine ([3]).
- the enzymes E1 and E2 are present in the three compartments of the plant cell, that is to say, the plastids, the cytosol and the mitochondria (5-6, 9, 12). These three enzymes are called El SAT2 and SAT4 for the enzyme (putative) chloroplast, SAT1 to the mitochondrial enzyme, SAT3 and SAT3 (SAT52) for the cytoplasmic enzyme. These attributions of the locations are based on the analysis of the sequences. For the enzymes of methionine synthesis, the situation is different since the enzymes E3 and E4 are exclusively located in the plasts (10-1 1, 13-14, 16), while the terminal enzyme E5 is in the cytosol (20).
- the enzymes associated with the glutathione biosynthetic pathway are localized in both the chloroplast and the cytosol ([21] Hell. R. and Bergmann. L .. Planta (1990) 180, 603-612).
- the enzyme E3 from the methionine synthesis pathway has a ⁇ ' m (substrate concentration giving half the maximum speed) of the order of 200 ⁇ M to 500 ⁇ M for cysteine (10, 16, [ 22] Kreft, BD. & Al. Plant Physiol. (1 994) 104, 1215-1220).
- the enzyme E6, from the glutathione synthesis pathway also has a high K m for cysteine, of the order of 200 ⁇ M [21].
- the present invention therefore consists in increasing the level of cysteine and methionine synthesized in the cellular compartments of plant cells, and in particular in the chloroplastic compartment. Increase in cysteine levels.
- Sulfur precursor of glutathione and methionine and its derivatives advantageously makes it possible to increase the level of methionine and / or glutathione in plant cells and plants, and subsequently to improve the production of proteins, natural or heterologous, enriched in sulfur amino acids in plant cells and plants, as well as plant tolerance to different stresses regulated by glutathione.
- This increase according to the invention is obtained by overexpressing a Serine acetyltransferase (SAT) in plant cells and plants.
- SAT Serine acetyltransferase
- the present invention therefore relates to a process for increasing the production of cysteine, glutathione, methionine and their sulfur derivatives, by plant cells and plants, said method comprising overexpressing SAT in plant cells. and plants containing said plant cells.
- the overexpressed SAT can be constituted by any SAT, whether it is of plant origin, in particular SAT2 or SAT4, SATl, SAT3, SAT3 ' (SAT52), or of any other origin, in particular bacterial, in a native or mutated form or deleted from a fragment, and functional in the synthesis of O-acetylserine.
- SAT sensitive to cysteine can in particular be a SAT sensitive to cysteine.
- a plant SAT for example a chloroplastic or mitochondrial SAT (SAT2.
- SAT insensitive SAT in the cysteine
- a SAT plant for example a cytoplasmic SAT (SAT-3), or an SAT of mutated bacterial, rendered insensitive cysteine mutaeénippoe J22] and [23] . the contents of which are incorporated here by reference
- the SAT is a SAT of Arabidopsis thaliana [12].
- the SAT is overexpressed in the cytoplasm of plant cells.
- the SAT is either a plant cytoplasmic SAT, in particular SAT 3 (L34076) or SAT3 'or SAT52 (U30298). represented by SEQ ID NO 1 or SEQ ID NO 2, respectively, or an SAT of bacterial origin as defined above.
- SAT overexpressed in the cytoplasm can also be a non-cytoplasmic plant SAT. for example a chloroplastic or mitochondrial SAT.
- non SAT cytoplasmic plant are naturally expressed in the cytoplasm in the form of a precursor protein comprising a signal targeting to different cell compartment of the cytoplasm wherein the functional mature SAT is released.
- SAT protein overexpressed in the cytoplasm is a SAT of a non-cytoplasmic plant amputated from its address signal or signals to different cellular compartments of the cytoplasm.
- the non amputated cytoplasmic SAT of its addressing signal is the LOAS 'represented by SEQ ID NO 3
- the SAT is overexpressed in the mitochondria.
- the protein is advantageously expressed in the cytoplasm in the form of a signal / S AT peptide fusion protein. the functional mature SAT being released inside the mitochondria.
- the signal peptide mitochondrial addressing is advantageously constituted by at least a mitochondrial targeting signal peptide of a plant protein mitochondrial localization as the signal peptide subunit / 3-F1 ATPase tobacco [[25] Hemon P . & al. 1990, Plant Mol. Biol. 15, 895-904], or the signal peptide of SAT1 represented by amino acids 1 to 63 on SEQ ID NO 4.
- mitochondrial SAT is the LOAS (U22964) represented by SEQ ID NO 4.
- the SAT is overexpressed in the chloroplasts of plant cells.
- the SAT will be expressed in chloroplasts by any appropriate means, in particular by any means known in the art and widely described in the prior art.
- the SAT is --incommunée in chloroplasts by integration into the chloroplast DNA of a chimeric gene comprising a DNA sequence encoding said SAT, under the control of regulatory elements in 5 'and 3' functional in chloroplasts.
- Techniques for inserting genes into chloroplasts, such as regulatory elements suitable for the expression of said genes in chloroplasts are well known to those skilled in the art, and in particular described in the following patents and patent applications: US 5,693,507, US 5,451, 513 and WO 97/32977.
- the SAT is overexpressed in the cytoplasm in the form of a fusion protein transit peptide / SAT.
- the transit peptide having the function of addressing the SAT to which it is fused towards the chloroplasts.
- functional mature SAT being released within the chloroplast after cleavage at the chloroplast membrane.
- SAT SAT can be a chloroplast of plant origin. like SAT2 or SAT4, represented by SAQ ID NO 5 or 6 respectively
- SAT can also be a plant cytoplasmic SAT or SAT of bacterial origin as defined above.
- SAT cytoplasmic also imply SAT non cytoplasmic amputated of their signal addressed to a different compartment of the cytoplasm as defined above.
- Transit peptides their structures, modes of operation and their use in the construction of chimeric genes for the targeting of a heterologous protein in chloroplasts, as well as chimeric transit peptides comprising several transit peptides are well known from those skilled in the art and widely described in the literature. These include patent applications following: EP 189 707, EP 218 571 and EP 508 909. and the references cited in these patent applications, the content of which is incorporated here by reference
- the SAT can be homologous or heterologous to the transit peptide.
- the fusion protein is the SAT2 or SAT4 protein expressed naturally in the chloroplasts of plant cells.
- the transit peptide may be a transit peptide of a SAT2, shown as amino acids 1 to 32 of SEQ ID 5, or the transit peptide of a SAT4. represented by amino acids 1 to 30 of SEQ ID NO 6, or else a transit peptide of another protein with plastid location, in particular the transit peptides defined below.
- Protein localization by means plastid protein expressed in the cytoplasm of plant cells in the form of a fusion protein transit peptide / protein, the mature protein is localized in the chloroplast after cleavage of the transit peptide.
- a plant EPSPS transit peptide is described in particular in patent application EP 218 571, while a plant ssu RuBisCO transit peptide is described in patent application EP 189 707.
- the transit peptide also comprises, between the C-terminal part of the transit peptide and the N-terminal part of the SAT, a sequence part of the mature N-terminal part of a protein with plastid localization, this part of sequence generally comprising less than 40 amino acids of the N-terminal part of the mature protein, preferably less than 30 amino acids, more preferably between 15 and 25 amino acids.
- Such transit peptide comprising a transit peptide fused to a portion of the N-terminal portion of a protein is located in plastids is in particular described in patent application EP 1 89 707, particularly for the transit peptide and part N-terminal of plant RuBisCO ssu.
- the transit peptide also comprises, between the C-terminal part of the N-terminal part of the mature protein and the N-terminal part of the SAT, a second transit peptide of a vegetable protein with plastid localization.
- this chimeric transit peptide comprising the association of several transit peptides is an optimized transit peptide (OTP) constituted by the fusion of a first transit peptide, with a sequence part of the mature N-terminal part d '' a protein with plastid localization, which is fused with a second transit peptide.
- OTP optimized transit peptide
- Such an optimized transit peptide is described in patent application EP 508 909, more particularly the optimized transit peptide comprising the transit peptide of the ssu RuBisCO of sunflower, fused to a peptide consisting of the 22 amino acids of the N-terminal part of the RuBisCO ssu of mature corn, fused to the transit peptide of the RuBisCO ssu of corn.
- the present invention also relates to a transit peptide / SAT fusion protein. in which the SAT defined above is heterologous to the transit peptide, and in which the transit peptide consists of at least one transit peptide of a natural plant protein with plastid location as defined above.
- nucleic acid sequence means a nucleotide sequence which may be of DNA or RNA type, preferably of DNA type, in particular double strand, whether it is of natural or synthetic origin, in particular a DNA sequence for which the codons coding for the fusion protein according to the invention will have been optimized as a function of the host organism in which it will be expressed, these optimization methods being well known to those skilled in the art.
- nucleic acid sequence coding for a SAT is the use of a nucleic acid sequence coding for a SAT according to the invention defined above, in particular for cytoplasmic addressing.
- mitochondrial or chloroplastic in a process for the transformation of plants, as a coding sequence making it possible to modify the content of cysteine, methionine and derivatives, and glutathione of transformed plants.
- This sequence can of course also be used in association with other gene (s) marker (s) and / or coding sequence (s) for one or more other agronomic properties.
- the present invention also relates to a chimeric gene (or expression cassette) comprising a coding sequence as well as heterologous 5 ′ and 3 ′ regulatory elements capable of functioning in a host organism, in particular plant cells or plants, the coding sequence comprising at least a sequence of nucleic acid encoding an SAT as defined above.
- host organism any mono or multicellular organism, lower or higher, into which the chimeric gene according to the invention can be introduced. It is a question in particular of bacteria, for example E. coli, yeasts, in particular of the genera
- plant cell any cell originating from a plant and which can constitute undifferentiated tissues such as calluses, differentiated tissues such as embryos, parts of plants, plants or seeds.
- plant means any differentiated multicellular organism capable of photosynthesis, in particular monocotyledons or dicotyledons, more particularly crop plants intended or not for animal or human food, such as corn, wheat, rapeseed, soy, rice, sugarcane, beet, tobacco, cotton, etc.
- the regulatory elements necessary for the expression of acid sequence nucleic acid coding for a fusion protein according to the invention are well known to those skilled in the art depending on the host organism. They include in particular promoter sequences, transcription activators, terminator sequences, including start and stop codons. The means and methods for identifying and selecting the regulatory elements are well known to those skilled in the art and widely described in the literature.
- the invention relates more particularly to the transformation of plants.
- promoter regulatory sequence in plants any promoter sequence of a gene expressing itself naturally in plants can be used, in particular a promoter expressing in particular in the leaves of plants, such as for example so-called promoters of original origin.
- bacterial, viral or vegetable or also so-called light-dependent promoters such as that of a gene for the small ribulose-biscarboxylase / oxygenase (RuBisCO) subunit of a plant or any suitable known promoter which can be used.
- promoters of plant origin promoters histone be mentioned as described in EP 0 507 698. or rice actin promoter (US 5,641, 876).
- the promoters of a plant virus gene mention will be made of that of the cauliflower mosaic (CAMV 19S or 35S). or the circovirus promoter (AU 689 31 1).
- promoter regulatory sequence specific for particular regions or tissues of plants and more particularly seed-specific promoters ([26] Datla, R. & al., Biotechnology Ann. Rev. (1997) 3, 269 - 296), in particular the promoters of napine (EP 255 378), of phaseoline. glutenin, zein. heliantinin (WO 92/17580). of albumin (WO 98/45460), the oélosine (WO 98/45461). ATS 1 or 1 ⁇ TS3 (WO 99/20275).
- promoter regulatory sequence other regulatory sequences which are located between the promoter and the coding sequence, such as transcription activators (“enhancer”), such as for example the translational activator of the tobacco mosaic virus (TMV) described in application WO 87/07644. or the tobacco etch virus (VTE) described by Carrington & Freed.
- transcription activators such as for example the translational activator of the tobacco mosaic virus (TMV) described in application WO 87/07644. or the tobacco etch virus (VTE) described by Carrington & Freed.
- any corresponding sequence of bacterial origin such as for example the terminator nos dAgrobaclerium tumefaciens, or of plant origin, such as for example a histone terminator as described in application EP 0 633 317, can be used.
- the present invention relates also a cloning and / or expression vector for the transformation of a host organism containing at least one chimeric gene as defined above.
- This vector also comprises the above chimeric gene. at least one origin of replication.
- This vector may comprise a plasmid, a cosmid, a bacteriophage or a virus, transformed by the introduction of the chimeric gene according to the invention.
- transformation vectors according to the host organism to be transformed are well known in the art and widely described in the literature.
- it s' will include a virus that can be used for the transformation of developed plants and further containing its own elements for replication and expression.
- the vector for transforming plant cells or plants according to the invention is a plasmid.
- the chimeric gene according to the invention may be employed in combination with a selectable marker gene, either in a single vector, both genes being associated convergently, divergently or collinear, or in two vectors employed simultaneously for the transformation of the host organism.
- selectable marker genes include the antibiotic resistance genes, the herbicide tolerance genes (bialaphos, glyphosate or isoxazoles), genes coding for easily identifiable enzymes such as the enzyme GUS (or GFP , * 'Green Fluorescent Protein "), genes coding for pigments or enzymes regulating the production of pigments in transformed cells.
- selection marker genes are described in particular in patent applications EP 242 236, EP 242 246, GB 2 197 653, WO 91/02071, WO 95/06128, WO 96/38567 or WO 97/04103.
- the invention also relates to a transforming host organisms method, in particular plant cells by integration of at least a sequence of nucleic acid or a chimeric gene as defined above, which transformation may be obtained by any appropriate known means, fully described in the specialized literature and in particular the references cited in the present application, more particularly by the vector according to the invention.
- a series of methods involves bombarding cells, protoplasts or tissues with particles to which the DNA sequences are attached.
- Another series of methods consists in using as a means of transfer into the plant a chimeric gene inserted in a Ti plasmid of Agrobacterium tumefaciens or Ri of Agrobacterium rhizogenes.
- Other methods can be used such as micro-injection or electroporation, or even direct precipitation in PEG.
- Those skilled in the art will choose the appropriate method depending on the nature of the host organism, in particular the plant cell or the plant.
- the present invention also relates to host organisms, in particular plant cells or plants, transformed and containing a chimeric gene defined above.
- the present invention also relates to plants containing cells transformed, especially plants regenerated from transformed cells.
- the regeneration is obtained by any suitable process which depends on the nature of the species, as for example described in the references above.
- the present invention also relates to the transformed plants resulting from the culture and / or the crossing of the regenerated plants above, as well as the seeds of transformed plants.
- the transformed plants obtainable according to the invention can be of the monocotyledon type such as for example cereals, sugar cane, rice and corn or dicotyledons such as for example tobacco, soybeans, rapeseed, cotton, beet, clover, etc.
- the plants transformed according to the invention may contain other genes of interest, conferring on plants new agronomic properties.
- genes conferring new agronomic properties on transformed plants there may be mentioned the genes conferring tolerance to certain herbicides, those conferring tolerance to certain insects, those conferring tolerance to certain diseases.
- Such genes are described in particular in patent applications WO 91/02071 and WO 95/06128.
- Mention may also be made of the genes modifying the constitution of the modified plants, in particular the content and quality of certain essential fatty acids (EP 666 91 8) or also the content and quality of the proteins, in particular in the leaves and / or seeds of said plants.
- proteins enriched in sulfur amino acids [1]; WO 98/20133; WO 97/41239; WO 95/3 1554; WO 94/20828; WO 92/14822, US 5,939,599 , US 5,912,424).
- These proteins enriched in sulfur amino acids will also have the function of trapping and storing cysteine and / or excess methionine, making it possible to avoid the possible problems of toxicity linked to an overproduction of these sulfur amino acids by trapping them.
- genes of interest may be combined with the chimeric gene according to the invention or by conventional crossing two plants each containing one of the genes (the first chimeric gene of the invention and the second gene coding for the protein interest) or by performing the transformation of plant cells of a plant containing the gene encoding the protein of interest with the chimeric gene of the invention.
- the three subcellular compartments corresponding to the cytosol are prepared from pea leaves (preparation from a subcellular fractionation of pea protoplasts. [12]). mitochondria and chloroplasts [12]. Soluble proteins are extracted therefrom and the serine acetyltransferase activity present in each of the compartments is measured using a technique described [12, 17].
- the activity of the serine acetyltransferase is measured by high performance liquid chromatography (HPLC), by assaying the O-acetylserine formed during the reaction (reaction 1), after derivatization with orthophthalaldehyde (OPA).
- HPLC high performance liquid chromatography
- OPA orthophthalaldehyde
- a defined amount of the protein extract. corresponding to cytosol. and to the various soluble fraction of chloroplasts (stroma) and mitochondria (matrix) is desalted on a PD10 column (Pharmacia) previously equilibrated in 50 mM Hepes-HCl buffer, pH 7.5 and 1 mM EDTA.
- the enzymatic reaction is carried out in the presence of 50 mM Hepes-HCl, pH 7.5, ImM dithiotreitol, 10 mM L-serine. 2.5 mM acetyl-CoA, in a reaction volume of 100 ⁇ l, at 25 ° C. After 10 to 15 min of incubation, the reaction is stopped by adding 50 ⁇ l of 20% trichloroacetic acid (W / V). The proteins thus precipitated are then removed by centrifugation for 2 min at 15,000 g.
- the supernatant, containing the reaction product (OAS), is mixed with 500 ⁇ l of a derivatization solution (54 mg of OPA dissolved in 1 ml of absolute ethanol, 9 ml of a borate -NaOH 400 solution mM, pH 9.5 and 0.2 ml of 14 M ⁇ -mercaptoethanol) and incubated for 2 min.
- a fraction of this mixture (20 ⁇ l) is injected onto a reverse phase column (AccQ Tag CJS column, 3.9 X 150 mm, Waters) connected to an HPLC system.
- the buffers used for the elution of the compounds derived from OPA are: Buffer A, 85 mM sodium acetate, pH 4.5, and 6% acetonitile (V / V), pH 4.5; Buffer B. acetonitrile. 60% (VV) in water.
- O-acetylserine, derived by OPA is eluted by a continuous linear gradient of buffer B in buffer A from 25 to 70% (V / V), and detected by fluorescence at 455 nm (excitation at 340 nm) .
- the retention time of O-acetylserine is in our conditions of the order of 6.2 min, and the amount of product formed in the enzymatic tests is quantified from a standard curve produced with O-acetylserine.
- the enzymatic tests have been optimized in order to respect the optimal pH of the reaction, the linearity as a function of time, and in order to operate in saturating concentrations of substrates.
- the concentration of L-cysteine allowing the obtaining of 50% inhibition (IC50) under the standard conditions of the reaction calculated for different enzymatic preparations is shown in Table I.
- the determinations of the enzymatic activity of the serine acetyltransferase and of the IC50 were carried out in 9 different experiments (stroma), and in 3 for cytosolic extracts and from the mitochondria.
- the activity of the serine acetyltransferase of the chloroplast of spinach leaves is sensitive to cysteine.
- Arabidopsis thaliana it appears that only the activity of the isoform associated with the cytosolic compartment is controlled by the level of cysteine ([27] Mr. Noji et al., 1998, J.
- the inhibition constant K ⁇ was estimated to be around 30 (+ 2.2) ⁇ M (variable substrate serine), and 22 ( ⁇ 2 ⁇ M) (variable substrate: acetyl- CoA).
- cysteine is an inhibitor of non-competitive type for serine acetyltransferase activity and moreover of allosteric type (Hill constant of the order of 1.6 ⁇ 0.3 ⁇ M) using kinetic equations.
- classics [29] Segel, IH (1995), John Wiley and Sons, New York).
- Serine acetyltransferase of the plant cell such as its bacterial homologous forms an enzymatic complex with o-acetylserine (thiol) lyase, the enzyme which catalyzes the condensation of the sulfur with reduced O-acetylserine.
- This bienzymatic complex is called cysteine synthase.
- All of the chloroplast serine acetyltransferase exists in a complex form with O-acetylserine (thiol) lyase, while the majority of O-acetylserine (thiol) lyase is in the free form.
- the distribution of each of these enzymes in each of the subcellular compartments of pea leaves is described in Table II.
- the ratio of the activity o-acetylserine (thiol) lyase ( ⁇ ASTL) by serine acetyltransferase activity (SAT) accounts for the large excess of OASTL on the SAT.
- ⁇ ASTL activity o-acetylserine
- SAT serine acetyltransferase activity
- O-acetylserine the reaction product of serine acetyltransferase, dissociates this bienzymatic complex, and sulfur tends to stabilize it [14].
- These protein-protein interactions within the complex confer new properties on each of the enzymes, in particular the serine acetyltransferase acquires new catalytic properties compared to the free form.
- O-acetylserine (thiol) lyase complex is inactive in the synthesis of cysteine. and only the free form (in excess in the cell) catalyzes the synthesis of cysteine [14].
- a chloroplastic fraction (Pisum sativum), previously incubated in the presence of an optimal concentration of cysteine (0J mM), leading to the inhibition of the serine acetyltransferase (see FIG. 2) is then subjected to a gel filtration chromatography allowing the separation molecules according to their molecular mass. Under these conditions the cysteine synthase complex dissociates into tetramers of serine acetyltransferase and dimers of O-acetylserine (thiol) lyase. The serine acetyltransferase chloroplast in its free form is always sensitive to inhibition by cysteine.
- SAT serine acetyltransferase
- ⁇ ASTL O-acetylserine
- the functional cysteine synthase complex in the cell is represented by the association of two molecular populations.
- cysteine the cysteine synthase complex fixes cysteine which modifies the protein-protein interactions within the cysteine synthase complex. and leads to dissociation into SAT tetramers and OASTL dimers.
- SAT thus in its free form is also sensitive to cysteine, and we know that this structure tends to form aggregates (outside the cysteine synthase complex) and which result in a loss of its activity [14].
- Example 2 Isolation and characterization of a gene coding for a putative cytoplasmic serine acetyltransferase isoform (SAT3) [12] The procedure described on page 502 of Ruffet & al. [12], in particular the chapters described under the titles "Bacterial strain and growth conditions” and "Isolation of A. thaliana serine acetyltransferase cDNA clones by complementation in E. coli". A gene coding for a putative cytosolic serine acetyltransferase (Z34888 or L34076) represented in FIG.
- SAT3 putative cytoplasmic serine acetyltransferase isoform
- the primers which were used for the amplification of the nucleotide sequence and its cloning into the vector used for the transformation of tobacco plants are the following: Oligo 1: 5 'GAGAGAGGAT CCTCTTTCCA ATCATAAACC ATGGCAACAT
- GCATAGACAC ATGC 3 'Oligo 2 5' GGCTCACCAG ACTAATACAC TAAATTGTGT TTACCTCGAG
- the N-terminus of the amino acid sequence of the SAT3 isoform does not have the characteristics of addressing peptides in an organelle (mitochondria or chloroplast). This analysis leads to suppose a cytosolic localization for this isoform [12]. The absence of a chloroplastic addressing peptide for this isoform could be confirmed during an import experiment in chloroplasts ([29]
- the SAT 3 gene (L34076) has a structure without introns.
- the protocol defined for the overexpression of the enzyme in E. coli allows the purification of the enzyme in its free form or in complex with the plant O-acetylserine (thiol) lyase, the cysteine synthase complex [14] .
- the effect of cysteine on the activity of serine acetyltransferase was analyzed by a spectrophotometric assay based on the consumption of acetyl-CoA during reaction i, as a function of the incubation time. .
- Example 3 The procedure of Example 3 is repeated with the following oligonucleotides 3 and 4:
- Oligo 3 5 * GAGAGAGGAT ⁇ TCTTATCG CCGCGTTAAT ATGCCACCGG CCGGAGAACTC C 3 'Oligo 4: 5' GAGCCTTACC AGTCTAATGT AGTATATTTC AACCTCGAGA
- GAGAG 3 'A gene coding for an acetyltransferase (U 30298) represented in FIG. 5 is isolated (SEQ ID NO 2).
- SEQ ID NO 2 The structure of the N-terminal (absence of the necessary conditions allowing addressing in an organelle) indicates that this isoform has a cytosolic localization.
- cysteine On the other hand, it is given sensitive to cysteine [27]. This result differs from the data obtained with pea (and spinach) leaves. in the sense that the cysteine regulatory site appears to be confined to the cytosol in A. thaliana. [27].
- J. lhaliana has at least two cytosolic isolates: SAT3 (example 3) and SAT3 '(or U30298. Example 4).
- the gene corresponding to SAT3 ' has an intron.
- a gene coding for a serine acetyltransferase (L78443) represented in FIG. 6 (SEQ ID NO 3) was isolated by functional complementation of a strain of Escherichta coli deficient for the serine acetyltransferase activity. [12] Analysis of the primary sequence shows strong similarities with the sequence of the bacterial enzyme (52.1% homology and 39% identity).
- the primers which were used for the amplification of the nucleotide sequence and its cloning in the vector used for the transformation of tobacco plants are the following:
- Oligo 5 5 'GAGAGAGGAT ⁇ CCTCCTCC TCCTCCTCCT ATGGCTGCGT GCATCGACAC CTG 3'
- Oligo 6 5 'GCTCACCAGC CTAATACATT AAACTTTTTC AGCTCGAGAG
- AGAG 3 These primers allow the instruction of the restriction sites BamHI in 5' (GGATCC) and Sacl in 3 '(GAGCTC).
- a second gene is obtained which codes for a putative mitochondrial serine acetyltransferase (U22964) represented in FIG. 7 (SEQ ID NO 4) by repeating the same procedure with oligo 7 in replacement of oligo 5 as primer in 5 '.
- the N-terminal end of the amino acid sequence of the SAT1 isoform has the characteristics of addressing peptides in an organelle (mitochondria or chloroplast). Mitochondrial localization has recently been confirmed by the construction of a fusion protein including the 5 'portion and the "green fluorescent protein" (5'SAT1-GFP) and by the transformation of Arabidopsis thaliana plants [27].
- the gene for SATl '(L78443) or SATl (U22964), like its counterpart (SAT3) does not have an intron.
- the protocol defined for the overexpression of the enzyme in E. coli allows the purification of the enzyme (in its form without transit peptide, SAT L78443) in its free form or in complex with O-acetylserine (thiol ) plant lyase, the cysteine synthase complex [14].
- the effect of cysteine on the activity of serine acetyltransferase was analyzed by a spectrophotometric assay based on the consumption of acetyl-CoA during reaction 1, as a function of the incubation time. (see example 3).
- the analysis was also carried out by an assay of the reaction product (OAS) by HPLC (see example 1).
- the mitochondrial fraction devoid of plastid and cytosolic contamination was obtained using the protocol defined for the mitochondria of pea leaves [12].
- the molecular mass of the polypeptide revealed by the antibodies directed against the peptide [-TKTLHTRPLLEDLDR-] (see amino acid sequence of SATl) is of the order of 34,000 daltons, a value which is in agreement with the mass of the protein obtained by sequence analysis programs for predicting cleavage sites.
- Example 3 The procedure described for Example 3 is repeated for the present example.
- a gene coding for a serine acetyltransferase (L78444) represented in FIG. 8 (SEQ ID NO 5) was isolated by functional complementation of a strain of Escherichia coli deficient for the serine acetyltransferase activity.
- SEQ ID NO 5 A gene coding for a serine acetyltransferase (L78444) represented in FIG. 8 (SEQ ID NO 5) was isolated by functional complementation of a strain of Escherichia coli deficient for the serine acetyltransferase activity.
- Analysis of the primary sequence showed the presence of strong similarities with the sequence of the bacterial enzyme (49.5% homology and 35.4% identity).
- the primers which were used for the amplification of the nucleotide sequence and its cloning into the vector used for the transformation of tobacco plants (in bold characters in FIG. 8 are the following:
- Oligo 8 5 'GAGAGAGGAT CCGACAAGTT GGCATAATTT ATGGTGGATC TATCTTCCT 3' Oligo 9: 5'CCTGTGTGAT TGTCGTGTAG TACTCTAGAA
- the primers which were used for the amplification of the nucleotide sequence and its cloning in the vector used for the transformation of tobacco plants are the following:
- Oligo 10 5 'GAGAGAGGAT ⁇ GACAAGTTGG CATAATTTAT GGCTTGTATA
- Oligo 11 5'TACCTCGTAC CACTCAGAAC TCTAGAAACT CGAGAGAGAG3 '
- the analysis of the N-terminal portion of the sequence has characteristics for addressing the protein in an organelle (mitochondria or chloroplast).
- the SAT 4 gene like that of SAT2, is complex and has several introns. Sequence comparison of the SAT4 with its counterparts in J. thaliana plants, and other organisms suggest an origin of prokaryotic-type ( Figure 10).
- analysis of the N-terminal sequence using the ChloroP program http://www.cbs.dtu.dk/services/chlorP/] indicates a high probability for the presence of a transit peptide chloroplastic type.
- Figure 10 represents the comparison of the sequences, it was carried out using the Clustavv program (Vector NTI software).
- SAT2 and SAT4 are closer to prokaryotic SATs than are SAT3, SATl and SAT52.
- the branch also includes a red alga SAT (AB00848) identified as a protein with a chloroplastic localization and sensitive to cysteine ([32] Toda & al. 1998, Biochim. Biophys. Acta 1403. 72-84) .
- SAT4 is identified on chromosome 4 (Bac clone F8D20, accession AL031 135).
- Example 8 Constructions used for the transformation of tobacco plants - small Havanna variety Expression of the transgene in the leaves
- Transformations of tobacco plants are carried out via Agrobacterium tuméfaciens EHA105, containing the vector pBI121 (Clonetch) ( Figures 1 1 and 12).
- SAT3 or SATl 'OR any SAT insensitive to cysteine
- a kanamycin resistance gene (NPTIl) coding for the neomycin phosphotransferase used as a selection marker for tobacco processing.
- the expression of the NPTI1 gene is dependent on the promoter and the terminator of the nopaline synthase of A. tumefaciens. Downstream, the? -Glucuronidase gene cloned between the unique sites ZtamHl and Sacl, is under the control of the cauliflower mosaic virus (CaMV) 35S promoter and the polyadenylation signal of the nopaline synthase gene from Ti plasmid.
- CaMV cauliflower mosaic virus
- OTP-SAT3 construct is carried out between the Xho and Sacl sites of the deleted vector of the / - -glucuronidase gene (FIG. 11) SAT1, SAT3, SAT3'- SAT2, SAT4 or all SATs
- NPTIl kanamycin resistance gene
- the promoter constituting the tobacco mosaic will be replaced by a promoter which allows
- the leaf discs are incubated for a few minutes with the agrobacteria solution and then transferred to MS medium (Sigma M-5519) supplemented with 0.05 mg / 1 of ⁇ -naphthalene acetic acid (NAA, Sigma). 2 mg / 1 of 6-benzylaminopurine (BAP) and 7 mg / 1 of phytoagar, for 2 to 3 days.
- the leaf discs are then transferred to an identical medium to which are added 350 mg / l of cefotaxine (bacteriostatic) and 75 mg / l of kanamycin (selection agent).
- the discs on which calluses have developed as well as young shoots are transplanted onto an identical medium in order to accelerate the growth of the shoots. A week later, the green shoots are excised and transferred to the same hormone-free medium, in order to allow the development of the roots, this for about 2 weeks, at the end of which the young plants are transferred to the ground and cultivated in the greenhouse.
- Example 10 Analysis of the results for the transgenic plants SAT3 and SATl '(L78443) (truncated form of SATl U22964) and controls.
- the determination of free methionine and SMM is carried out by the methods of determination of free amino acids after extraction and derivation by orthophthaldehyde and separation by HPLC ([34] Brunet, P. & al., J. Chrom. (1988 ) 455, 173-182).
- the measurement of the activity of the serine acetyltransferase is carried out as described in the assay methodology for the O-acetylserine formed, by the HPLC technique, or by the coupling method in the presence of an excess of O-acetylserine. (thiol) lyase [12], [14].
- the activity of the SAT transgene in transformed plants i.e. in vivo
- the extracts are taken up in 0.1 M hydrochloric acid (1 ml / 100 mg of powder). After an incubation period of around 10 min, the debris is removed by centrifugation for 15 min at 15,000 g. A fraction of the supernatant obtained, containing the free amino acids is derivatized for 1 min at 25 ° C in the presence of a solution of ortho-phthalaldehyde (54 mg solution of ortho-phthalaldehyde, 10% methanol, 90% sodium borate 400 mM, pH 9.5, and 0.2 ml of /? - mercaptoethanol).
- ortho-phthalaldehyde 54 mg solution of ortho-phthalaldehyde, 10% methanol, 90% sodium borate 400 mM, pH 9.5, and 0.2 ml of /? - mercaptoethanol.
- the OPA-amino acid derivatives are then separated by reverse phase chromatography on a UPHDO-15M column (0.46 x 150 mm, Interchim) connected to an HPLC system (Waters).
- the buffers used to carry out the elution are, Buffer A: sodium acetate, 85 mM, pH 4.5 supplemented with final 6% acetonitirile; buffer B: 60% acetonitrile in water.
- the separation of the derivatives is carried out according to the gradient (1 ml / min): 0 min. 30% B in A; 8 min, 60% B in A; 9 min, 80% B in A; 10 min, 100% B; 12 min, 100% B.
- the fluorescence emitted by the derivatives is measured at 455 nm after excitation at 340 nm (fluorimeter SFM25, Kontron).
- the retention time of O-acetylserine under our experimental conditions is 9.5 min.
- the identity of the peak corresponding to O-acetylserine is confirmed by co-elution with a known quantity of the pure product.
- a second check was carried out to confirm the position of O-acetylserine in the various analyzes.
- the samples, before incubation with the OPA, are previously treated with final 0.2 M NaOH. Under these conditions, the acetate function in the OH position of the serine is transferred to the amine function and thus allowing the formation of .V-acetylserine. The latter compound is no longer detected under our experimental conditions and therefore leads to the disappearance of the peak corresponding initially to O-acetylserine.
- Plant analyzes include: 1; Demonstration of the transgene insertion in the genome by PCR using the primers 5 'and 3' corresponding to the SAT used for transformation; 2, as evidenced by an analysis of the messenger messengers using probes corresponding to the SAT transgenes used for the transformation of plants according to known techniques; 3, demonstration of the enzymatic activity associated with the SAT protein according to the methods described in the literature ([14]) and localization of the transgene; 4. dosage of the SAT reaction product, i.e.
- O-acetylserine ( ⁇ AS) in transformed plants 5, determination of cysteine and its direct derivatives, glutathione and methionine (and its methylated derivatives); 5, analysis of the total amino acid composition of plants and seeds associated with each of the transgenes obtained (free amino acids and bound to proteins) according to traditional techniques; 6; analysis of the impact of over-e xpression of SAT activity in the plant cell on the content of enzymatic activity associated with the sulfur assimilation sequence (sulfate transporters, ATP-sulfurylase, APS reductase, sulfite reductase and in particular O-acetylserine (thiol) lyase, the enzyme directly associated with SAT activity for the synthesis of cysteine ([14]).
- the enzymes associated with the synthesis sequence of methionine and glutathione are analyzed in order to account for the impact of the cysteine content on the metabolism associated with the synthesis of glutathione and methionine.
- Expression of the Arabidopsis thaliana serine acetyltransferase gene in tobacco leads to an increase in the cysteine level, the glutathione level and the methionine level in the tissues of transformed plants compared to the control plants. In general, this increase in the content of free sulfur compounds is associated with the expression of the transgene in the plant cell (FIG. 13). The measurement is made in the leaves of 3 different plants of each homozygous line. The SAT activity is measured by its capacity to promote the synthesis of cysteine according to the protocol described above ([14]).
- the expression of the transgene under the control of the constitutive promoter CaMV leads to increasing the capacity (the maximum potential enzymatic activity measured in vitro) of the SAT by a factor 2 to 8 compared to the level measured in the control plants (transformed plants with an empty vector).
- a measure of the content o-acetylserine (free ⁇ AS) was performed.
- the level of OAS in the plant cell average rate of 4 nmol / g fresh matter for the control plants, 6 independent measurements
- the sub-cellular localization of the SAT1 '(truncated form of SAT1) and SAT3 transgenes in the transformed tobacco plants could be clarified by preparing the chloroplast fraction of the transformed plants having the highest enzymatic activity compared to the plants PBI (controls). The activity associated with the chloroplast compartment is compared with that measured in the total extract ( Figure 16).
- the serine acetyltransferase activity values correspond to 3 lines for PBI (5 plants per line), 5 lines for SAT1 'and SAT3 represented by 5 plants each.
- the columns in gray correspond to activities measured in total realized extracted from each of the lines, and black columns represent the average of the measured activity in each chloroplast preparations.
- cysteine A direct consequence of the increased level of cellular cysteine results in increased synthesis of glutathione and methionine (see Figure 1).
- the fate of cysteine is multiple and apart from its incorporation at the protein level, its participation in the synthesis of multiple compounds such as vitamins (biotin, thiamine, ... and other sulfur derivatives of the cell), cysteine also participates to the synthesis uu glutathione (t ⁇ peptide associated with many defense mechanisms of the plant and considered as a reservoir of cysteine) and methionine.
- the level of glutathione is directly correlated to that of cysteine and results in an increase of 2 to 7 times the natural rate measured in controlled plants (PBI) ( Figure 17).
- the correlation coefficient calculated for the distribution of points is 0.92.
- a 4-fold increase in the content of Cysteine in transgenic tobacco plants overexpressing SAT results in a 3-4 fold increase in the level of glutathione.
- the analysis was carried out with fully developed leaves (approximately 2 months) of plants homozygous for the transgene. Control plants are transformed plants with empty constructs. This result indicates that cysteine is the limiting factor for the synthesis of glutathione in the plant cell. Therefore, indirectly any modification of the level of serine acetyltransferase in the cell will result, via the increase in the level of cysteine, an increase in the content in intra-cellular glutathione. This result implies that the transgenic plants obtained have acquired stress resistance properties compared to the control plants (PBI).
- cysteine and glutathione considered a reservoir leads to increased availability in the synthesis of polypeptides rich in cysteine (for example for resistance to plant pathogenic attacks) and cysteine rich in methionine (for animal feed)
- the maximum shelf obtained under our experimental conditions is about 39 +/- 7 nmol / g fresh material methionine which corresponds to an increase of the average natural rate of about 6 +/- 2 per g material namole fresh (PBI control).
- the maximum value obtained for methionine requires an increase in the cysteine content of the cell from 4 to 5 times its maximum level.
- the regression coefficient is 0.50.
- SMM S-methylmethionine
- the SMM derives directly from methionine methylathion in the presence of S-adenosylmethionine.
- This compound is important for the cell and is a form of transport of methyl groups (of methionine) in the plant.
- homocysteine a sulfur precursor for the synthesis of methionine and cysteine derived
- the MMS allows the synthesis of two molecules of methionine ([3], [35], & Bourgis al., 1999, Plant Cell 1 1 J 485-1497).
- SMM is the direct precursor for the synthesis of a compound such as 3-dimethylsulfoniopropionate involved in the resistance of plants to salt stress ([36], Hanson AD & al., 1994, Plant PhysiolJ 05, 103-1 10) .
- salt stress [36], Hanson AD & al., 1994, Plant PhysiolJ 05, 103-1 10) .
- Such an approach has multiple consequences, in particular for increasing the potential of plants on soils rich in salts.
- the serine acetyltransferase is considered a limiting factor for the sulfur assimilation and synthesis of cysteine. Its role in bacteria is important since the reaction product, (O-acetylserine. ⁇ AS) or its derivative (N-acetylserine) is the effector which modulates the expression of the genes of the sulfur assimilation sequence as : 1. transport of sulfate. 2, ATP sulfurylase. 3. APS kinase. And 4, PAPS reductase ([37], Kredich NM, 1987, in Escherichia coli and Salmonella typhimurium: cellular and molecular biology, pp. 419-428).
- the equivalent amount of protein (50 mg) is subjected to an SDS-PAGE (12%) and after separation of the proteins, these are transferred to a nitrocellulose membrane.
- the presence of the OASTL is revealed by incubation with antibodies against OASTL chloroplast of leaf spinach ([7]).
- the overexpression of SAT in the plant cell therefore leads to increasing the capacity to synthesize cysteine in the chloroplast. It is therefore safe to assume that the expression of the genes coding for the enzymes of the sulfate assimilation and reduction pathway (sulfate transporter, ATP sulfurylase, APS reductase, sulfite reductase) is also modulated like OASTL (and references [38-41]).
- the increase in intracellular OAS content (which derives from the activity of
- SAT signals an artificial state of sulfur stress (absence of sufficient reduced sulfur) to the cell (in transformed plants) which leads to inducing the enzymes of the sulfate assimilation pathway.
- Example 12 Analysis of the results for the SAT1 transgenic plants (CDNA U22964 or SATlj, form with transit peptide) and controls.
- the methionine content is multiplied by 2 to 3 times compared to the natural level measured in the control plants.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nutrition Science (AREA)
- Medicinal Chemistry (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU17830/00A AU773031B2 (en) | 1998-12-17 | 1999-12-17 | Method for increasing the content in sulphur compounds and particularly in cysteine, methionine and glutathione in plants and plants obtained |
CA002355255A CA2355255A1 (fr) | 1998-12-17 | 1999-12-17 | Procede pour augmenter la teneur en composes soufres et notamment en cysteine, methionine et glutathion chez les plantes et plantes obtenues |
BR9916968-1A BR9916968A (pt) | 1998-12-17 | 1999-12-17 | Método de aumento da produção de cisteìna, glutationa, metionina e seus derivados de enxofre, vetor, gene quimérico, sequência de ácido nucleico, organismo hospedeiro transformado, célula vegetal, planta geneticamente modificada e suas sementes |
EP99961099A EP1141349A1 (fr) | 1998-12-17 | 1999-12-17 | Procede pour augmenter la teneur en composes soufres et notamment en cysteine, methionine et glutathion chez les plantes et plantes obtenues |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9816163A FR2787466B1 (fr) | 1998-12-17 | 1998-12-17 | Procede pour augmenter la teneur en cysteine, methionine et glutathion chez les plantes et plantes obtenues |
FR98/16163 | 1998-12-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000036127A1 true WO2000036127A1 (fr) | 2000-06-22 |
Family
ID=9534264
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR1999/003179 WO2000036127A1 (fr) | 1998-12-17 | 1999-12-17 | Procede pour augmenter la teneur en composes soufres et notamment en cysteine, methionine et glutathion chez les plantes et plantes obtenues |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1141349A1 (fr) |
AR (1) | AR028807A1 (fr) |
AU (1) | AU773031B2 (fr) |
BR (1) | BR9916968A (fr) |
CA (1) | CA2355255A1 (fr) |
FR (1) | FR2787466B1 (fr) |
WO (1) | WO2000036127A1 (fr) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6576819B1 (en) | 1999-02-18 | 2003-06-10 | Pioneer Hi-Bred International, Inc. | Methods for modulating the levels of organic sulfur compounds in plants by transforming with (P)APS reductase DNA |
US6608239B1 (en) | 1998-07-07 | 2003-08-19 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Means and methods for enhancing the content of sulfur compounds in plants |
WO2004053134A1 (fr) | 2002-12-12 | 2004-06-24 | Bayer Cropscience S.A. | Cassette d'expression codant pour la 5-enolpyruvylshikimate-3-phosphate synthase (epsps) et plantes tolerantes aux herbicides en contenant |
WO2004058934A3 (fr) * | 2002-12-23 | 2004-09-02 | Sungene Gmbh & Co Kgaa | Procede pour produire des plantes transgeniques a teneur accrue en vitamine e par modification de la teneur en serine-acetyltransferase |
US6831206B2 (en) | 2001-05-21 | 2004-12-14 | Stephen M. Allen | Serine O-acetytransferase |
US7038109B1 (en) | 2001-03-29 | 2006-05-02 | Pioneer Hi-Bred International, Inc. | Enzymatic methods for modulating the levels of organic sulfur compounds in plants |
WO2010079117A2 (fr) | 2009-01-07 | 2010-07-15 | Bayer Cropscience Ag | Plantes transplastomiques dépourvues du marqueur de sélection |
WO2011095460A1 (fr) | 2010-02-02 | 2011-08-11 | Bayer Cropscience Ag | Transformation du soja faisant appel à des inhibiteurs de l'hppd en tant qu'agents de sélection |
EP2395088A1 (fr) * | 2009-09-25 | 2011-12-14 | Instytut Biochemii I Biofizyki Pan | Molécule ADN recombinante, vecteur, cellule végétale et cassette d'expression végétale produisant de grandes quantités de synthase de cystéine fonctionnellement active et utilisation associée |
US9051575B2 (en) | 2010-08-31 | 2015-06-09 | Japan Science And Technology Agency | Alga in which production of photosynthetic products is improved, and use for said alga |
US10138490B2 (en) | 2002-09-11 | 2018-11-27 | Michel Matringe | Transformed plants tolerant to herbicides due to overexpression of prephenate dehydrogenase and p-hydroxyphenylpyruvate dioxygenase |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10104721B4 (de) * | 2001-02-02 | 2006-02-09 | IPK-Institut für Pflanzengenetik und Kulturpflanzenforschung | Verfahren zur Erhöhung des Gehalts von Schwefelverbindungen in Pflanzen |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997015673A1 (fr) * | 1995-10-26 | 1997-05-01 | Consortium für elektrochemische Industrie GmbH | Procedes de preparation de o-acetylserine, l-cysteine et produits apparentes a la l-cysteine |
WO1998055601A2 (fr) * | 1997-06-06 | 1998-12-10 | E.I. Du Pont De Nemours And Company | Enzymes de biosynthese d'acides amines d'origine vegetale |
WO2000004167A2 (fr) * | 1998-07-14 | 2000-01-27 | E.I. Du Pont De Nemours And Company | Genes codant des proteines d'assimilation du sulfate |
-
1998
- 1998-12-17 FR FR9816163A patent/FR2787466B1/fr not_active Expired - Fee Related
-
1999
- 1999-12-16 AR ARP990106473A patent/AR028807A1/es not_active Application Discontinuation
- 1999-12-17 EP EP99961099A patent/EP1141349A1/fr not_active Withdrawn
- 1999-12-17 AU AU17830/00A patent/AU773031B2/en not_active Ceased
- 1999-12-17 CA CA002355255A patent/CA2355255A1/fr not_active Abandoned
- 1999-12-17 WO PCT/FR1999/003179 patent/WO2000036127A1/fr not_active Application Discontinuation
- 1999-12-17 BR BR9916968-1A patent/BR9916968A/pt not_active IP Right Cessation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997015673A1 (fr) * | 1995-10-26 | 1997-05-01 | Consortium für elektrochemische Industrie GmbH | Procedes de preparation de o-acetylserine, l-cysteine et produits apparentes a la l-cysteine |
WO1998055601A2 (fr) * | 1997-06-06 | 1998-12-10 | E.I. Du Pont De Nemours And Company | Enzymes de biosynthese d'acides amines d'origine vegetale |
WO2000004167A2 (fr) * | 1998-07-14 | 2000-01-27 | E.I. Du Pont De Nemours And Company | Genes codant des proteines d'assimilation du sulfate |
Non-Patent Citations (9)
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6608239B1 (en) | 1998-07-07 | 2003-08-19 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Means and methods for enhancing the content of sulfur compounds in plants |
US6576819B1 (en) | 1999-02-18 | 2003-06-10 | Pioneer Hi-Bred International, Inc. | Methods for modulating the levels of organic sulfur compounds in plants by transforming with (P)APS reductase DNA |
US7038109B1 (en) | 2001-03-29 | 2006-05-02 | Pioneer Hi-Bred International, Inc. | Enzymatic methods for modulating the levels of organic sulfur compounds in plants |
US7560623B2 (en) | 2001-03-29 | 2009-07-14 | Pioneer Hi-Bred International, Inc. | Enzymatic methods for modulating the levels of organic sulfur compounds in plants |
US6831206B2 (en) | 2001-05-21 | 2004-12-14 | Stephen M. Allen | Serine O-acetytransferase |
US7186890B2 (en) | 2001-05-21 | 2007-03-06 | E.I. Dupont De Nemours And Company | Serine O-acetyltransferase |
US10138490B2 (en) | 2002-09-11 | 2018-11-27 | Michel Matringe | Transformed plants tolerant to herbicides due to overexpression of prephenate dehydrogenase and p-hydroxyphenylpyruvate dioxygenase |
WO2004053134A1 (fr) | 2002-12-12 | 2004-06-24 | Bayer Cropscience S.A. | Cassette d'expression codant pour la 5-enolpyruvylshikimate-3-phosphate synthase (epsps) et plantes tolerantes aux herbicides en contenant |
WO2004058934A3 (fr) * | 2002-12-23 | 2004-09-02 | Sungene Gmbh & Co Kgaa | Procede pour produire des plantes transgeniques a teneur accrue en vitamine e par modification de la teneur en serine-acetyltransferase |
WO2010079117A2 (fr) | 2009-01-07 | 2010-07-15 | Bayer Cropscience Ag | Plantes transplastomiques dépourvues du marqueur de sélection |
EP2395088A1 (fr) * | 2009-09-25 | 2011-12-14 | Instytut Biochemii I Biofizyki Pan | Molécule ADN recombinante, vecteur, cellule végétale et cassette d'expression végétale produisant de grandes quantités de synthase de cystéine fonctionnellement active et utilisation associée |
WO2011095460A1 (fr) | 2010-02-02 | 2011-08-11 | Bayer Cropscience Ag | Transformation du soja faisant appel à des inhibiteurs de l'hppd en tant qu'agents de sélection |
US9051575B2 (en) | 2010-08-31 | 2015-06-09 | Japan Science And Technology Agency | Alga in which production of photosynthetic products is improved, and use for said alga |
JP5771616B2 (ja) * | 2010-08-31 | 2015-09-02 | 国立研究開発法人科学技術振興機構 | 光合成産物の生産性を向上させた藻類およびその利用 |
Also Published As
Publication number | Publication date |
---|---|
FR2787466B1 (fr) | 2001-02-16 |
AR028807A1 (es) | 2003-05-28 |
BR9916968A (pt) | 2002-01-08 |
AU1783000A (en) | 2000-07-03 |
CA2355255A1 (fr) | 2000-06-22 |
AU773031B2 (en) | 2004-05-13 |
EP1141349A1 (fr) | 2001-10-10 |
FR2787466A1 (fr) | 2000-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1537216B1 (fr) | Plantes transformees a biosynthese de prenylquinones amelioree | |
CA2061835C (fr) | Promoteurs d'histone | |
US7323338B2 (en) | Plants characterized by an increased content of methionine and related metabolites, methods of generating same and uses thereof | |
WO2000036127A1 (fr) | Procede pour augmenter la teneur en composes soufres et notamment en cysteine, methionine et glutathion chez les plantes et plantes obtenues | |
US6608239B1 (en) | Means and methods for enhancing the content of sulfur compounds in plants | |
WO2000070016A2 (fr) | Plantes genetiquement modifiees tolerantes vis-a-vis de conditions de stress | |
EP1153135B1 (fr) | Procedes permettant de moduler les taux de composes organiques contenant du soufre dans des plantes | |
Avraham et al. | The expression level of threonine synthase and cystathionine-γ-synthase is influenced by the level of both threonine and methionine in Arabidopsis plants | |
FR2848570A1 (fr) | Cassette d'expression codant pour une 5-enol pyruvylshikimate-3-phosphate synthase (epsps) et plantes tolerantes aux herbicides la contenant | |
US6558922B1 (en) | Methods and compositions for production of floral scent compounds | |
EP1244792B1 (fr) | Procede d'obtention de plantes a teneur enrichie en cysteine et glutathion | |
AU2004210597B2 (en) | Means and methods for enhancing the content of sulfur compounds in plants | |
WO2002000890A1 (fr) | Acides nucleiques codant pour une phosphatase vegetale de type mipp a activite phytasique et applications | |
EP1074629A1 (fr) | Protéines pièges | |
AU2002255254A1 (en) | Increased methionine in transgenic plants expressing mutant cystathionine gamma-synthase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENP | Entry into the national phase |
Ref country code: AU Ref document number: 2000 17830 Kind code of ref document: A Format of ref document f/p: F |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09486334 Country of ref document: US |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1999961099 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 17830/00 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2355255 Country of ref document: CA Ref country code: CA Ref document number: 2355255 Kind code of ref document: A Format of ref document f/p: F |
|
WWP | Wipo information: published in national office |
Ref document number: 1999961099 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWG | Wipo information: grant in national office |
Ref document number: 17830/00 Country of ref document: AU |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999961099 Country of ref document: EP |